-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
January 01, 2010 - Misclassification of drug metabolizer status, along with
the possibility that it might result in excessive or inadequate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0399_01-07-2011.pdf
January 01, 2011 - approximately 80 percent of
patients are not surgical candidates because of advanced stage disease, inadequate
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/mhs-IV-epc-grand-rounds-slides.pptx
January 01, 2023 - Facilitators
Barriers
Lack of training and confidence
High volume of workload
Gaps in communication
Inadequate … monitoring
Patient reluctance and expectations
Lack of a comprehensive approach
Inadequate access to … include lack of care protocols and algorithms, less than optimal team membership and/or skill sets, and inadequate … & Resources: Implementing RRS faces challenges like miscommunication, poor staff collaboration, and inadequate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-3-acute-pain.pdf
June 01, 2022 - Exclusion reason: Inadequate
duration
36. Chen W, Sun JN, Hu ZH, et al. … Exclusion reason: Inadequate
duration
149. … Exclusion reason: Inadequate duration
209. Tctr. … Exclusion reason: Inadequate
duration
241. Yoon Y, Ko M, Cho I, et al. … Exclusion reason: Inadequate duration
252. Zhu L, Li L, Yin B, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - Exclusion reason: Inadequate
duration
11. Aly E, Masocha W. … Exclusion reason:
Inadequate duration
37. … Exclusion reason: Inadequate duration
121. Mazza M. … Exclusion reason:
Inadequate duration
180. Swogger MT, Walsh Z. … Exclusion reason:
Inadequate duration
204. White CM.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - • There was inadequate information available to
assess the effect of rFVIIa dosage. … • There was inadequate information available to
assess the effect of rFVIIa dosage. … • There was inadequate information available to
assess the effect of rFVIIa dosage.
10
Key Question … • There was inadequate information available to
assess the effect of rFVIIa dosage. … • There was inadequate information available to
assess the effect of rFVIIa dosage.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - Other issues raised by the publication were inadequate data, which prevented careful
analysis of important … informative but also pointed out that the data and strength of evidence for other
conclusions were inadequate … The other expert pointed
out that the data and strength of evidence are inadequate for the conclusions … This suggests that the
difference in magnitude between these three
studies may be due to inadequate … This suggests that the difference in magnitude
between these three studies may be due to inadequate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - Other issues raised by the publication were inadequate data, which prevented careful
analysis of important … informative but also pointed out that the data and strength of evidence for other
conclusions were inadequate … The other expert pointed
out that the data and strength of evidence are inadequate for the conclusions … This suggests that the
difference in magnitude between these three
studies may be due to inadequate … This suggests that the difference in magnitude
between these three studies may be due to inadequate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-2-acute-pain.pdf
May 01, 2022 - Exclusion
reason: Inadequate duration
82. Khaw D, Bucknall T, Considine J, et al. … Exclusion reason:
Inadequate duration
92. Lam L, Richardson MG, Zhao Z, et al. … Exclusion reason: Inadequate
duration
152. Solanki SL, Thota RS, Rajan J, et al. … Exclusion reason: Inadequate duration
158. Tctr. … Exclusion reason: Inadequate
duration
186. Yu XJ, Zhang L, Lu WY, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - Exclusion reason: Inadequate duration
11. Aly E, Masocha W. … Exclusion reason: Inadequate duration
30. Blake A, Wan BA, Malek L, et al. … Exclusion reason: Inadequate
duration
43. … Exclusion reason:
Inadequate duration
200. Swogger MT, Walsh Z. … Exclusion reason: Inadequate duration
226. White CM.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence.ppt
January 01, 2010 - May be unnecessary, inappropriate, inadequate, or impractical
May be too short in duration
May report … RCTs may be unnecessary, inappropriate, inadequate, or impractical and, thus, not useful for answering … The quality and quantity of harms reporting is frequently inadequate. … within RCTs is a secondary consideration, the quality and quantity of harms reporting is frequently inadequate
-
effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence.ppt
January 01, 2010 - May be unnecessary, inappropriate, inadequate, or impractical
May be too short in duration
May report … RCTs may be unnecessary, inappropriate, inadequate, or impractical and, thus, not useful for answering … The quality and quantity of harms reporting is frequently inadequate. … within RCTs is a secondary consideration, the quality and quantity of harms reporting is frequently inadequate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
December 31, 2013 - Alogliptin as a third oral
antidiabetic drug in patients with
type 2 diabetes and inadequate
glycaemic … switching from sitagliptin to
exenatide twice daily in patients with
type 2 diabetes experiencing
inadequate … 30 mg/day)
Piogliatzone (15
or 30 mg/day)
with placebo RCT
339 type 2 diabetes
patients with
inadequate … Linagliptin add-
on to metformin
Metformin with
placebo RCT
701 subjects with
type 2 diabetes and
inadequate … metformin
Glipizide added
to metformin
RCT
(post
hoc
analysis
of data)
1,172 subjects with
inadequate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-executive-summary.pdf
March 01, 2025 - Systematic Review on Risk of Cardiovascular Disease
• A majority of the included studies reported inadequate … Type 2 Diabetes, Growth, Size, and Body
Composition
• A majority of the included studies reported inadequate … The available
literature suffers from serious limitations due to inadequate adjustment of confounding
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide-2nd-edition_disposition-comments.pdf
March 03, 2010 - Is this a general comment, or a specific comment on
inadequate sample size? … Inadequate outcome definition or outcome
specification? Inadequate control of confounding? … Is this
a general comment, or a specific comment on inadequate sample size,
inadequate outcome definition … , inadequate outcome specification, or
inadequate control of confounding variables?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/grading-quiz.ppt
May 29, 2025 - Insufficient implies either that one has no relevant evidence or that the evidence is so mixed and inadequate
-
effectivehealthcare.ahrq.gov/sites/default/files/grading-quiz.ppt
May 29, 2025 - Insufficient implies either that one has no relevant evidence or that the evidence is so mixed and inadequate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
June 01, 2016 - Data are inadequate to address the role of imaging in
guiding IH treatment. … Other Findings of the Review
��Data are inadequate to address the role of imaging in
guiding IH treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
May 01, 2022 - Exclusion
reason: Inadequate duration
79. Khaw D, Bucknall T, Considine J, et al. … Exclusion reason:
Inadequate duration
89. Lam L, Richardson MG, Zhao Z, et al. … Exclusion reason: Inadequate duration
153. Tctr. … Exclusion reason: Inadequate
duration
174. Yu R, Zhuo Y, Feng E, et al. … Exclusion reason: Inadequate
duration
175. Yu XJ, Zhang L, Lu WY, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - study design yet I
am not certain we have a clear definition of what
constitutes inadequate study … For example,
what is the difference between high risk of bias and
inadequate study design. … The most
frequent reason was inadequate follow up time
(i.e. less than 6 months). … The most frequent reason was
inadequate follow up time (i.e. less than 6
months). … The most frequent reason was
inadequate follow up time (i.e. less than 6
months).